How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gile...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical tri...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical trial operations while working to develop lifesaving interventions. At Gilead Sciences, this need to quickly pivot led to an increase...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical trial operations while working to develop lifesaving interventions. At Gilead Sciences, this need to quickly pivot led to an increase...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical tri...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and patient insights both d...
The healthcare industry relies on real-world data more and more to make informed and effective decisions and the COVID-1...
December, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confidence...
November 24, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confide...
Building a modern data infrastructure within today’s healthcare enterprise is challenging on many levels. Your organizat...
October 19, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confiden...
© 2020 HealthVerity, Inc. | Terms & Conditions | Privacy Policy
© 2020 HealthVerity, Inc. | Terms & Conditions | Privacy Policy